EYE REVITAL | Legacy™ RF for Eye
Venus Legacy™ provides safe, pain-free, immediate, and long-term results for eye contouring, wrinkle reduction and skin tightening for the eyes, face, neck and body. RF delivers focused heat, faster than other treatments, to various tissue depths targeting and disabling fat cells while also stimulating the growth of new collagen.
- Puffiness under the eyes
- Deep lines and wrinkles
- Droopy eyes and brows
- RF (radio frequency) reorganizes the collagen and restructures the skin, replacing old, damaged collagen with new collagen. The new skin appears smoother and more youthful.
- The PEMF (Pulsed Electro Magnetic Fields) increases circulation in the area, reducing the puffiness seen by slow moving fluid in the eye area. As well, PEMF increase the amount of fibroblasts in the skin which create new collagen.
- With an increase in the abundance of collagen, the skin is not so transparent and vessels which used to be visible under the skin appear less blue and pink.
The CLINIC's specialist places a protective and smooth lotion of the skin called Glide. The applicator is then applied to the skin with gentle, slow, massaging like movements covering the entire area. As the skin begins to respond to the energy heat is created deep in the dermis and a comfortable warming sensation occurs.
The treatment takes approximately 30-45 minutes and it feels like a warm gentle massage.
- No downtime, no surgery, and no pain or discomfort
- Most patients typically see results after the third treatment, however, many have noted results even sooner. With FDA approval, Venus Legacy has documented itʼs results to last a minimum 18 months but will continue to last ongoing if one session per quarter is maintained after series.
*Note: As this is a medical procedure, results & outcomes are not guaranteed and may vary from person to person.
To book your complimentary consultation with our experts, please fill in our secure online appointment request form below or contact the CLINIC today by calling +852 2538 8868.